Development of synthetic aminopeptidase N/CD13 inhibitors to overcome cancer metastasis and angiogenesis

ACS Medicinal Chemistry Letters

Volumn 3, Issue 12, 2012, Pages 959-964

  Su, Li ^a   Cao, Jiangying ^a   Jia, Yuping ^a   Zhang, Xiaonan ^a   Fang, Hao ^a   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

angiogenesis; anticancer; APN CD13; inhibitors; metastasis

Indexed keywords

AMINOPEPTIDASE N INHIBITOR; ANTIMETASTATIC AGENT; BESTATIN; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER PATIENT; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG TARGETING; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 84871256917     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml3000758     Document Type: Article

References (29)

1. Francia, G.; Cruz-Munoz, W.; Man, S.; Xu, P.; Kerbel, R. S. Mouse models of advanced spontaneous metastasis for experimental therapeutics Nat. Rev. Cancer 2011, 11, 135-141
2. Klein, C. A. The Metastasis Cascade Science 2008, 321, 1785-1787
3. Wirtz, D.; Konstantopoulos, K.; Searson, P. C. The physics of cancer: the role of physical interactions and mechanical forces in metastasis Nat. Rev. Cancer 2011, 11, 512-522
4. Chaffer, C. L.; Weinberg, R. A. A Perspective on Cancer Cell Metastasis Science 2011, 331, 1559-1564
5. Sang, Q.; Jin, Y.; Newcomer, R.; Monroe, S.; Fang, X.; Hurst, D.; Lee, S.; Cao, Q.; Schwartz, M. Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases Curr. Top. Med. Chem. 2006, 6, 289-316
6. Wickstrom, M.; Larsson, R.; Nygren, P.; Gullbo, J.; Aminopeptidase, N. (CD13) as a target for cancer chemotherapy Cancer Sci. 2011, 102, 501-508
7. Antczak, C.; Meester, I. D.; Bauvois, B. Ectopeptidases in pathophysiology Bioessays 2001, 23, 251-260
8. Rawlings, N.; Barrett, A. MEROPS The peptidase database 1999, 27 (1) 325-331
9. Furuhashi, M.; Mizutani, S.; Kurauchi, O.; Kasugai, M.; Narita, O.; Tomoda, Y. In vitro degradation of opioid peptides by human placental aminopeptidase M Exp. Clin. Endocrinol. 1988, 92, 235-237
10. Hoffmann, T.; Faust, J.; Neubert, K.; Ansorge, S. Dipeptidyl peptidase IV (CD26) and Aminopeptidase N (CD13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences FEBS Lett. 1993, 336, 61-64
11. Antczak, C.; De Meester, I.; Bauvois, B. Transmembrane proteases as disease markers and targets for therapy J. Biol. Regul. Homeostasis Agents 2001, 15, 130-139
12. Carmelit, P.; Jain, R. Angiogenesis in cancer and other diseases Circ. Res. 2000, 87, 176-178
13. Bauvois, B.; Dauzonne, D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects Med. Res. Rev. 2006, 26, 88-130
14. Amoscato, A.; Stamkoski, R.; Babcock, G.; Alexande, J. Neutral surface aminopeptidasc activity of human tumor cell lines Biochem. Biophys. Acta 1990, 1041, 317-319
15. Kawamura, J.; Shimada, Y.; Kitaichi, H.; Komoto, I.; Hashimoto, Y.; Kaganoi, J.; Miyake, M.; Yamasaki, S.; Kondo, K.; Imamura, M. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma Hepatogastroenterology 2007, 54, 36-40
16. Rich, D.; Moon, B. J.; Harbeson, S. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes J. Med. Chem. 1984, 27, 417-422
17. Scornik, O.; Botbol, V. Bestatin as an experimental tool in mammals Curr. Drug Metab. 2001, 2, 67-85
18. Leyhausen, G.; Schuster, D.; Vaith, P.; Zahn, R.; Umezawa, H.; Falke, D.; Muller, W. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immuno-stimulant and chemotherapeutic agent bestatin Biochem. Pharmacol. 1983, 32, 1051-1057
19. Saiki, I.; Yoneda, J.; Azuma, I.; Fujii, H.;; Abe, F.; Nakajima, M.; Tsuruo, T. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation Int. J. Cancer 1993, 54, 137-143
20. Ito, K.; Nakajima, Y.; Onohara, Y.; Takeo, M.; Nakashima, K.; Matsubara, F.; Ito, T.; Yoshimoto, T. Aminopeptidase n (Proteobacteria alanyl aminopeptidase) from escherichia coli: crystal structure and conformational change of the methionine 260 residue involved in substrate recognition J. Biol. Chem. 2006, 281, 33664-33676
21. Su, J.; Wang, Q.; Feng, J.; Zhang, C.; Zhu, D.; Wei, T.; Xu, W.; Gu, L. Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug development Bioorg. Med. Chem. 2011, 19, 2991-2996
22. Saiki, I.; Murata, J.; Watanabe, K.; Fujii, H.; Abe, F.; Azuma, I. Inhibition of tumor cell invasion by Ubenimix (bestatin) in vitro Jpn. J. Cancer Res. 1989, 80, 873-878
23. Zhao, H.; Liu, H.; Chen, Y.; Xin, X.; Li, J.; Hou, Y.; Zhang, Z.; Zhang, X.; Xie, C.; Geng, M.; Ding, J. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis Cancer Res. 2006, 66, 8779-8787
24. Talmadge, J.; Zbar, B. Clonality of pulmonary metastases from the bladder 6 subline of the B16 melanoma studied by southern hybridization J. Natl. Cancer Inst. 1987, 78, 315-320
25. Aozuka, Y.; Koizumi, K.; Saitoh, Y.; Ueda, Y.; Sakurai, H.; Saiki, I. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice Cancer Lett. 2004, 216, 35-42
26. Gude, R. P.; Binda, M. M.; Boquete, A. L.; Bonfil, R. D. Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline J. Cancer Res. Clin. Oncol. 2001, 127, 625-630
27. Sidky, Y. A.; Auerbach, R. Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs-host reaction J. Exp. Med. 1975, 141, 1084-1100
28. Li, Q.; Fang, H.; Wang, X.; Hu, L.; Xu, W. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I Eur. J. Med. Chem. 2009, 44, 4819-4825
29. Tsai, J.; Takaoka, L.; Powell, N.; Nowick, J. Synthesis of amino acid ester isocyanates Org. Synth. 2002, 78, 220-224